Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Male
Adult
Risk
Connectivity
Cross-Over Studies
Adolescent
610
Brain
Clinical High Risk for Psychosis
Oxytocin
Magnetic Resonance Imaging
Article
3. Good health
Young Adult
Psychotic Disorders
Double-Blind Method
Graph Theory
616
Connectome
Humans
Nerve Net
Administration, Intranasal
DOI:
10.1101/2023.03.17.23286528
Publication Date:
2023-03-21T15:45:24Z
AUTHORS (20)
ABSTRACT
ABSTRACT Abnormalities in functional brain networks (functional connectome) are increasingly implicated people at Clinical High Risk for Psychosis (CHR-P). Intranasal oxytocin, a potential novel treatment the CHR-P state, modulates network topology healthy individuals. However, its connectomic effects remain unknown. Forty-seven men (30 and 17 controls) received acute challenges of both intranasal oxytocin 40 IU placebo two parallel randomised, double-blind, placebo-controlled cross-over studies. Multi-echo resting-state fMRI data was acquired approximately 1h post-dosing. Using graph theoretical approach, group (CHR-P vs control), (oxytocin placebo) respective interactions were tested on metrics describing connectome. Group observed 12 regions (all p FDR <.05) most localised to frontoparietal network. Treatment found 7 predominantly within ventral attention Our major finding that many differ across individuals, with significant interaction numerous subcortical strongly psychosis onset, such as thalamus, pallidum nucleus accumbens, cortical which primarily default mode (12 regions, all <.05). findings provide new insights aberrant organisation associated risk demonstrate, first time, pathophysiology clinical status control) specific manner. Further profiling connectomic, cognitive this population is warranted.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (100)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....